Manzo Pharmaceuticals, Inc.
MNZO · OTC
12/31/2015 | 12/31/2014 | 12/31/2004 | 12/31/2003 | |
|---|---|---|---|---|
| Market Cap | $1 | $0 | $2 | $3 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | -$0 | $0 | $7 | $7 |
| Enterprise Value | $1 | $0 | $8 | $10 |
| Revenue | $0 | $0 | $3 | $3 |
| % Growth | 267.5% | -100% | 2.2% | – |
| Gross Profit | $0 | $0 | $0 | $1 |
| % Margin | 39.4% | 100% | 0.7% | 25.2% |
| EBITDA | $0 | -$0 | -$3 | -$2 |
| % Margin | 39.4% | -81,886.5% | -93% | -76.5% |
| Net Income | -$0 | -$1 | -$4 | -$4 |
| % Margin | -1,799.6% | -180,493.8% | -135.2% | -131.6% |
| EPS Diluted | -0 | -0.003 | -1.2 | -1.2 |
| % Growth | 98.9% | 99.8% | 0% | – |
| Operating Cash Flow | – | – | -$1 | -$2 |
| Capital Expenditures | – | – | -$0 | -$0 |
| Free Cash Flow | – | – | -$1 | -$2 |